Articles by Anthony Farino - Pharmaceutical Executive

ADVERTISEMENT

Articles by Anthony Farino

Risky Business

Accurate and ethical price reporting is a compulsory, albeit confusing, practice for pharmaceutical manufacturers.
Apr 1, 2005

Every quarter, pharmaceutical manufacturers confront a dizzying array of price reporting obligations. Participation in the Medicare, Medicaid, Veterans Administration (VA), and Public Health Service (PHS) programs requires manufacturers to collect, organize, distill and manipulate vast quantities of information, and to generate from that data reportable figures that can have an enormous impact on the company's bottom line. It is critical that these figures be correct, not only to help ensure the integrity of these public programs, but because submission of false data to a federal agency is a prosecutable criminal offense, and the civil penalties and exposure can be staggering.

Caught in the Crosshairs: Pharmaceutical Pricing and Sales & Marketing Practices

Scrutiny of the industry is on the rise, and Pharma companies must establish compliance programs now.
Apr 1, 2002

The pharmaceutical industry stands in the crosshairs of federal and state law enforcement agencies. It is not being targeted by FDA for regulatory violations, as one would expect, but by many other government agencies

ADVERTISEMENT

Click here